Browsing eNauka

Browsing by Author Matytsina, Irina

Showing results 1 to 11 of 11
Issue DateTitleAuthor(s)TypeМp-cat.
2018A New Dosing Model Based on Body Mass Index to Guide Factor VIII Dosing in Patients with Hemophilia ATiede, Andreas; Goldmann, Georg; Miljic, Predrag S; Korsholm, Lars; Matytsina, Irina; Persson, Paula; Jelev, Lissitchkov ToshkoConference Paper
Mp. category will be shown later
2020Body Mass Index Best Predicts Recovery of Recombinant Factor VIII in Underweight to Obese Patients with Severe Haemophilia ATiede, Andreas; Rosa, Cid Ana; Goldmann, Georg; Jimenez-Yuste, Victor; Pluta, Michael; Lissitchkov, Toshko; May, Marcus; Matytsina, Irina; Miljic, Predrag S; Pabinger, Ingrid;
Persson, Paula;
Article
21aM21a
2014Changes in Annualized Bleeding Rate over Time and Relationship with Dosing of Turoctocog Alfa during the guardian(TM) ProgramLandorph, Andrea; Santagostino, Elena; Zeuthan, Niels; Ozelo, Margareth Castro; Matytsina, Irina; Janic, Dragana M  Conference Paper
Mp. category will be shown later
2015Changes in Annualized Bleeding Rate Over Time and Relationship with Dosing of Tutoctocog a During the Guardian ProgramMancuso, ME; Ozelo, M; Janic, Dragana M  ; Matytsina, Irina; Landorph, Andrea; Zeuthan, Niels; Roveda, A; Pellegrino, GConference Paper
Mp. category will be shown later
2016Efficacy and safety of turoctocog alfa for prophylaxis and treatment of bleeding episodes in patients with severe hemophilia A: results from the guardian (TM) 2 trialJanic, Dragana M  ; Karim, Faraizah Abdul; Matytsina, Irina; Ozelo, Margareth Castro; Savic, Aleksandar D  ; Tiede, Andreas; Oldenburg, JohannesConference Paper
Mp. category will be shown later
2018Long-term safety and efficacy of turoctocog alfa in prophylaxis and treatment of bleeding episodes in severe haemophilia A: Final results from the guardian 2 extension trialLentz, Steven R; Janic, Dragana M  ; Kavakli, Kaan; Miljic, Predrag S  ; Oldenburg, Johannes; Ozelo, Margareth Castro; Santagostino, Elena; Suzuki, Takashi; Zupancic-Salek, Silva; Korsholm, Lars;
Matytsina, Irina; Tiede, Andreas;
Научни чланак
21M21 - Водећи међународни часопис категорије M21
2015PO251-WED Interim results from a large multinational extension trial (Guardian TM2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia ALentz, SR; Kempton, CL; Janic, Dragana M  ; Savic, Aleksandar D  ; Cerqueira, MH; Ozelo, MC; Recht, M; Oldenburg, J; Tiede, Andreas; Suzuki, Takashi;
Matytsina, Irina; Zeuthen, N; Santagostino, E;
Conference Paper
Mp. category will be shown later
2015Prior Treatment Regimen Influences Annualised Bleeding Rate During Long- Term Prophylaxis With Turoctocog Alfa: Experiences From Multinational TrialsLaguna, P; Savic, Aleksandar D  ; Matytsina, Irina; Zeuthen, NConference Paper
Mp. category will be shown later
2015Safety of Turoctocog Alfa for The Prevention and Treatment of Bleeds in Patients with Haemophilia A: Results for The Guardian (TM) Clinical TrialsMatytsina, Irina; Janic, Dragana M  ; Lejniece, Sandra; Santagostino, EConference Paper
Mp. category will be shown later
2017Spontaneous Bleeding Rate On Turoctocog Alfa Prophylaxis in a Large Cohort of Patients With Haemophilia A Followed For up to 5 Years - Trends Over Time and Across GeographySantagostino, E; Martin, Salces M; Lejniece, Sandra; Janic, Dragana M  ; Tripkovic, N; Matytsina, IrinaConference Paper
Mp. category will be shown later
2018Use of turoctocog alfa for less-frequent prophylaxis in selected patients has comparable efficacy with the overall prophylaxis cohort in Guardian (TM) 2Tiede, Andreas; Janic, Dragana M  ; Ozelo, M; Santagostino, E; Korsholm, Lars; Matytsina, Irina; Lentz, SRConference Paper
Mp. category will be shown later